Portfolio company
Adjutecpharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AdjutTec
This pharmaceutical company develops antibiotic resistance breakers to treat patients with multidrug-resistant bacterial and fungal infections.
Discuva
This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Omnix Medical
This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.
Abgentis
This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.
Nabriva
This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.
Acurx Pharmaceuticals
This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.